Skip to content
Menu

Metagenomi Therapeutics, Inc. MGX

Full chart Compare
Set alert

Price alert · MGX

All alert types
0.61 USD -0.02 (-2.85%)

Regular-session close

0.61 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

0.61 Day range 0.6423
0.60 52-week range 1.87
YTD
-62.11%
1 year
-61.88%

MGX revenue history

Revenue is income from the company’s ordinary business activities.

25,210,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3125,210,000-27,085,000-51.79%
FY 20242024-12-3152,295,0007,539,00016.84%
FY 20232023-12-3144,756,00027,556,000160.21%
FY 20222022-12-3117,200,00016,957,0006978.19%
FY 20212021-12-31243,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:42:13.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.